In conclusion, in this explorative study we demonstrated that Rac1-corrected pSTAT3 protein levels in T-lymphocytes seem a specific pharmacodynamic marker for thiopurine therapy in IBD patients, and may be a potential tool to optimize thiopurine therapy in clinical practice. The gene discussed is RAC1; the disease is inflammatory bowel disease.